Literature DB >> 35716180

Spondyloarthritis in familial Mediterranean fever: a cohort study.

Sevtap Acer Kasman1, Mehmet Tuncay Duruöz2.   

Abstract

Familial Mediterranean fever (FMF) and spondyloarthritis (SpA) may show several common signs. This study aimed to evaluate the frequency of SpA and its manifestations in FMF, the impact of SpA on FMF, and the associations of non-episodic findings (heel enthesitis, protracted arthritis, and sacroiliitis) with the FMF features. Demographic, clinical, imaging, and genetic data were retrieved from medical records of the patients with adult FMF. To identify patients who met the classification criteria for SpA, data including rheumatologic inquiry were recorded. Patients with SpA and those who did not meet the criteria were compared in terms of FMF features. Regression analyses were performed to determine the factors that were most associated with sacroiliitis, enthesitis, and protracted arthritis. Of the 283 patients with FMF, 74 (26.1%) met the SpA criteria (64 axial, 10 peripheral); and 65 (22.9%) patients had sacroiliitis, 27 (9.5%) protracted arthritis, and 61 (21.6%) heel enthesitis. Patients with SpA were older and had more FMF severity, and heel pain rate than those without; however, genetic features, CRP, resistance to colchicine, and heel enthesitis did not differ. A meaningful number of patients without SpA had also displayed heel enthesitis, protracted arthritis, inflammatory back pain, heel pain, family history of SpA, and elevated CRP. Age was found to be the main predictor of heel enthesitis and protracted arthritis was linked with FMF severity. A significant number of patients with FMF meet the peripheral SpA classification criteria as well as axial SpA. SpA and its shared manifestations with FMF may have an impact on FMF.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Arthritis; Enthesopathy; Familial Mediterranean fever; Sacroiliitis; Spondylarthropathies

Mesh:

Year:  2022        PMID: 35716180     DOI: 10.1007/s00296-022-05158-5

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   3.580


  38 in total

Review 1.  Autoinflammatory conditions: when to suspect? How to treat?

Authors:  Gilles Grateau; Mehmet Tuncay Duruöz
Journal:  Best Pract Res Clin Rheumatol       Date:  2010-06       Impact factor: 4.098

Review 2.  Familial Mediterranean fever.

Authors:  E Ben-Chetrit; M Levy
Journal:  Lancet       Date:  1998-02-28       Impact factor: 79.321

3.  Evaluation of co-existing diseases in children with familial Mediterranean fever.

Authors:  Mehmet Yildiz; Amra Adrovic; Emre Tasdemir; Khanim Baba-Zada; Muhammed Aydin; Oya Koker; Sezgin Sahin; Kenan Barut; Ozgur Kasapcopur
Journal:  Rheumatol Int       Date:  2019-07-27       Impact factor: 2.631

4.  Familial Mediterranean fever is associated with a wide spectrum of inflammatory disorders: results from a large cohort study.

Authors:  Nuh Atas; Berkan Armagan; Erdal Bodakci; Hasan Satis; Alper Sari; Nazife Sule Yasar Bilge; Reyhan Bilici Salman; Gozde Kubra Yardımcı; Hakan Babaoglu; Aslihan Avanoglu Guler; Hazan Karadeniz; Levent Kilic; Mehmet Akif Ozturk; Berna Goker; Seminur Haznedaroglu; Umut Kalyoncu; Timucin Kasifoglu; Abdurrahman Tufan
Journal:  Rheumatol Int       Date:  2019-08-07       Impact factor: 2.631

5.  Seronegative spondyloarthropathy in familial Mediterranean fever.

Authors:  P Langevitz; A Livneh; D Zemer; J Shemer; M Pras
Journal:  Semin Arthritis Rheum       Date:  1997-10       Impact factor: 5.532

Review 6.  Familial Mediterranean fever-related spondyloarthropathy.

Authors:  P Borman; F Gökoğlu; O Taşbaş; M Yilmaz; Z R Yorgancioğlu
Journal:  Singapore Med J       Date:  2009-03       Impact factor: 1.858

7.  Enthesopathy in patients with familial Mediterranean fever: increased prevalence in M694 V variant.

Authors:  Abdurrahman Tufan; Rıdvan Mercan; Mehmet Engin Tezcan; Arif Kaya; Berivan Bitik; Mehmet Akif Ozturk; Seminur Haznedaroglu; Berna Goker
Journal:  Rheumatol Int       Date:  2013-01-20       Impact factor: 2.631

8.  The frequency of sacroiliitis in familial Mediterranean fever and the role of HLA-B27 and MEFV mutations in the development of sacroiliitis.

Authors:  Timuçin Kaşifoğlu; Cüneyt Calişir; Döndü U Cansu; Cengiz Korkmaz
Journal:  Clin Rheumatol       Date:  2008-09-16       Impact factor: 2.980

9.  Enthesitis may be one of the signs of severe disease in familial Mediterranean fever.

Authors:  Nesrin Sen; Mesut Yilmaz; Ridvan Mercan; Omur Volkan; Sibel Yilmaz-Oner; Ezgi Tukel; Mehmet Engin Tezcan
Journal:  Clin Rheumatol       Date:  2020-09-12       Impact factor: 2.980

10.  High prevalence of spondyloarthritis and ankylosing spondylitis among familial Mediterranean fever patients and their first-degree relatives: further evidence for the connection.

Authors:  Servet Akar; Ozgul Soysal; Ali Balci; Dilek Solmaz; Vedat Gerdan; Fatos Onen; Mehmet Tunca; Nurullah Akkoc
Journal:  Arthritis Res Ther       Date:  2013-01-28       Impact factor: 5.156

View more
  1 in total

1.  Clinical and functional impact of central sensitization on patients with familial Mediterranean fever: a cross-sectional study.

Authors:  Feyza Nur Yücel; Halise Hande Gezer; Janbubi Jandaulyet; Nuran Öz; Sevtap Acer Kasman; Mehmet Tuncay Duruöz
Journal:  Rheumatol Int       Date:  2022-08-12       Impact factor: 3.580

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.